Working… Menu
Trial record 83 of 498 for:    LENALIDOMIDE AND every 28 days

Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01180569
Recruitment Status : Withdrawn
First Posted : August 12, 2010
Last Update Posted : September 25, 2015
Celgene Corporation
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : May 2011
Actual Study Completion Date : May 2011